Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.

Quick facts

Phase 2 pipeline

• ANC-501

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc. portfolio CI brief
• Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc. pipeline updates RSS